ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,539Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 617

$741K Total Retail Price of All Prescriptions

Rank: 20 out of 617

411 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 411 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 411 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 10,284 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
WARFARIN SODIUM 807 765 1 7
LEVOTHYROXINE SODIUM 618 548 2 1
PRAVASTATIN SODIUM 398 358 3 21
AMLODIPINE BESYLATE 344 332 4 6
ATORVASTATIN CALCIUM 323 273 5 14
BYSTOLIC 305 286 6 64
FUROSEMIDE 299 285 7 4
CARVEDILOL 264 263 8 19
HYDROCODONE-ACETAMINOPHEN 253 202 S3 9 8
METFORMIN HCL 219 175 10 9
RAMIPRIL 214 195 11 67
NAMENDA 214 214 11 35
OMEPRAZOLE 197 181 13 3
GABAPENTIN 196 175 14 16
DONEPEZIL HCL 163 161 15 30
MIRTAZAPINE 137 127 16 50
CRESTOR 134 129 17 28
POTASSIUM CHLORIDE 126 108 18 10
CARBIDOPA-LEVODOPA 122 122 19 69
LOSARTAN POTASSIUM 119 119 20 22
ZOLPIDEM TARTRATE 113 110 21 23
TRICOR 112 108 22 83
EXELON 111 111 23 156
HYDROCHLOROTHIAZIDE 110 110 24 13
BENAZEPRIL HCL 107 104 25 44
SPIRIVA 106 71 26 61
METOPROLOL SUCCINATE 104 104 27 12
CHLORTHALIDONE 103 101 28 123
PREDNISONE 103 98 28 31
LISINOPRIL 101 91 30 5
LANTUS 92 72 31 39
DIOVAN 91 91 32 41
ALLOPURINOL 87 87 33 27
METOPROLOL TARTRATE 86 79 34 11
ESCITALOPRAM OXALATE 82 80 35 65
FLUTICASONE PROPIONATE 78 64 36 36
TRAMADOL HCL 78 71 36 15
VERAPAMIL ER 78 74 36 90
JANUVIA 75 48 39 107
NEXIUM 74 48 40 43
LIPITOR 68 50 41 118
GLIMEPIRIDE 67 54 42 33
OXYCODONE HCL 65 55 S2 43 130
SYNTHROID 64 64 44 59
SERTRALINE HCL 64 64 44 20
PANTOPRAZOLE SODIUM 63 51 46 37
TRIAMCINOLONE ACETONIDE 63 60 46 102
HUMALOG 61 58 48 152
LANTUS SOLOSTAR 57 56 49 115
PEN NEEDLE 57 55 49 174
VESICARE 56 44 51 95
ALENDRONATE SODIUM 56 56 51 25
CYMBALTA 56 30 51 49
CEPHALEXIN 56 51 51 68
CITALOPRAM HBR 55 50 55 18
LOSARTAN-HYDROCHLOROTHIAZIDE 53 44 56 46
FENOFIBRATE 52 42 57 58
TAMSULOSIN HCL 51 44 58 26
HYDRALAZINE HCL 51 51 58 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.